SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014)

doi:10.1016/j.canlet.2020.05.010

	SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014)
	Wang, Lu 2; Ai, Jing 2; Shen, Yanyan 2; Zhang, Haotian 2,4; Peng, Xia 2; Huang, Min 2; Zhang, Ao 1,3; Ding, Jian 2; Geng, Meiyu 2
刊名	CANCER LETTERS
	2020-08-28
卷号	486 页码:71-72
ISSN号	0304-3835
DOI	10.1016/j.canlet.2020.05.010
通讯作者	Ding, Jian(jding@simm.ac.cn) ; Geng, Meiyu(mygeng@simm.ac.cn)
WOS研究方向	Oncology
语种	英语
出版者	ELSEVIER IRELAND LTD
WOS记录号	WOS:000540255500008
内容类型	期刊论文
源URL	[http://119.78.100.183/handle/2S10ELR8/291714]
专题	中国科学院上海药物研究所
通讯作者	Ding, Jian; Geng, Meiyu
作者单位	1.Chinese Acad Sci, Shanghai Inst Mat Med, Synthet Organ & Med Chem Lab SOMCL, Shanghai 201203, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China 4.Shenyang Pharmaceut Univ, Dept Pharmacol, 103 Wenhua Rd, Shenyang 110016, Peoples R China
推荐引用方式 GB/T 7714	Wang, Lu,Ai, Jing,Shen, Yanyan,et al. SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014)[J]. CANCER LETTERS,2020,486:71-72.
APA	Wang, Lu.,Ai, Jing.,Shen, Yanyan.,Zhang, Haotian.,Peng, Xia.,...&Geng, Meiyu.(2020).SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014).CANCER LETTERS,486,71-72.
MLA	Wang, Lu,et al."SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014)".CANCER LETTERS 486(2020):71-72.